Effects of high-dose lisinopril-isosorbide dinitrate on severe mitral regurgitation and heart failure remodeling.
暂无分享,去创建一个
[1] S. Keteyian,et al. Reverse remodeling in heart failure with intensification of vasodilator therapy , 1997, Clinical cardiology.
[2] W. Parmley,et al. Beneficial Effects of Vasodilator Agents in Severe Mitral Regurgitation Due to Dysfunction of Subvalvar Apparatus , 1973, Circulation.
[3] F. Khaja,et al. Left ventricular shape as a determinant of functional mitral regurgitation in patients with severe heart failure secondary to either coronary artery disease or idiopathic dilated cardiomyopathy. , 1991, The American journal of cardiology.
[4] K. Swedberg,et al. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). , 1988, The American journal of cardiology.
[5] J. Cohn. Structural basis for heart failure. Ventricular remodeling and its pharmacological inhibition. , 1995, Circulation.
[6] G. A. Moore,et al. Effect of captopril on functional mitral regurgitation in dilated heart failure: a randomised double blind placebo controlled trial. , 1994, British heart journal.
[7] L. Stevenson,et al. Predictability of mitral regurgitation detected by Doppler echocardiography in patients referred for cardiac transplantation. , 1987, The American journal of cardiology.
[8] H N Sabbah,et al. Left ventricular shape changes during the course of evolving heart failure. , 1992, The American journal of physiology.
[9] R. Tarazi,et al. Long-term captopril therapy in congestive heart failure: serial hemodynamic and echocardiographic changes. , 1982, American heart journal.
[10] M. Quiñones,et al. Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction. Results of the SOLVD echocardiography substudy. , 1995, Circulation.
[11] M. Schwaiger,et al. Effects of afterload reduction (diuretics and vasodilators) on left ventricular volume and mitral regurgitation in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. , 1987, The American journal of cardiology.
[12] S. R. Cohen,et al. Contribution of reduced mitral regurgitant volume to vasodilator effect in severe left ventricular failure secondary to coronary artery disease or idiopathic dilated cardiomyopathy. , 1986, The American journal of cardiology.
[13] R A Levine,et al. Insights from three-dimensional echocardiography into the mechanism of functional mitral regurgitation: direct in vivo demonstration of altered leaflet tethering geometry. , 1997, Circulation.
[14] F. Tristani,et al. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. , 1991, The New England journal of medicine.
[15] S. Yusuf,et al. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators. , 1992, Circulation.
[16] M. Bristow,et al. Medical therapy can improve the biological properties of the chronically failing heart. A new era in the treatment of heart failure. , 1996, Circulation.
[17] J. Cohn,et al. Early ventricular remodeling after myocardial damage and its attenuation by converting enzyme inhibition. , 1990, Transactions of the Association of American Physicians.
[18] Salim Yusuf,et al. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.
[19] S. Goldstein,et al. Effects of long-term therapy with enalapril on severity of functional mitral regurgitation in dogs with moderate heart failure. , 1995, Journal of the American College of Cardiology.
[20] M. Woo,et al. Sustained reduction in valvular regurgitation and atrial volumes with tailored vasodilator therapy in advanced congestive heart failure secondary to dilated (ischemic or idiopathic) cardiomyopathy. , 1991, The American journal of cardiology.